 |
5 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- AMG 151 / Amgen
Trial termination: Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects (clinicaltrials.gov) - Apr 18, 2013
P1, N=5, Terminated, Sponsor: Amgen
Recruiting --> Terminated; Amgen determined no further need for this study.
- AMG 151 / Amgen
Enrollment change: Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects (clinicaltrials.gov) - Apr 18, 2013
P1, N=5, Terminated, Sponsor: Amgen
Recruiting --> Terminated; Amgen determined no further need for this study. N=26 --> 5
- |||| AMG 151 / Amgen
Trial completion: AMG 151 Amgen Protocol Number 20100761 (clinicaltrials.gov) - Mar 28, 2013
P2, N=236, Completed, Sponsor: Amgen
N=26 --> 5 Recruiting --> Completed
- AMG 151 / Amgen
New P1 trial: Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects (clinicaltrials.gov) - Dec 20, 2012
P1, N=5, Terminated, Sponsor: Amgen
- ||||| AMG 151 / Amgen
New P2 trial: AMG 151 Amgen Protocol Number 20100761 (clinicaltrials.gov) - Nov 1, 2011
P2, N=236, Completed, Sponsor: Amgen